Literature DB >> 31696485

LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.

N Zhang1, F-L Liu, T-S Ma, Z-D Zeng J-J Zhang.   

Abstract

OBJECTIVE: Neuroblastoma is a common malignancy in children. Despite the occurrence of diverse therapies in recent years, the survival rate of patients with high-risk NB is still unpredictable due to the high metastatic potential and poor prognosis. Therefore, it is urgent to study the molecular mechanism of NB metastasis. SNHG1 has been reported to be closely related to the development, metastasis, and prognosis of many cancers. The purpose of this study was to clarify the molecular mechanism of the role of SNHG1 in NB tumors. PATIENTS AND METHODS: The expression levels of SNHG1, miR-338-3p, and PLK4 were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot, respectively. The functional targets between miR-338-3p and SNHG1 or PLK4 were predicted by online software Diana tools and observed by Luciferase reporter assay and RIP assay. Cell proliferation was measured by MTT assay. Cell migration and invasion were operated through flow cytometry. The expression of p-AKT was quantified by Western blot. Xenograft tumor model was established to confirm the biological role of SNHG1 in NB in vivo.
RESULTS: The expression levels of SNHG1 and PLK4 were increased in NB tissues and cells, and miR-338-3p expression was on the contrary. PLK4 was verified as a direct target of miR-338-3p and miR-338-3p could specially bind to SNHG1. The negative effect of SNHG1 down-regulation on cell proliferation, migration, and invasion could be rescued by miR-338-3p inhibition. The suppression of miR-338-3p mimics on cell proliferation, migration, and invasion could be reversed by PLK4 overexpression. In addition, SNHG1 knockdown weakened the volume and weight of tumor in vivo.
CONCLUSIONS: SNHG1 conduced to tumorigenesis and mechanism by upregulating PLK4 and by acting as miR-338-3p sponge in neuroblastoma.

Entities:  

Year:  2019        PMID: 31696485     DOI: 10.26355/eurrev_201910_19296

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  Upstream open reading frames control PLK4 translation and centriole duplication in primordial germ cells.

Authors:  Thao P Phan; Christina A Boatwright; Chelsea G Drown; Marnie W Skinner; Margaret A Strong; Philip W Jordan; Andrew J Holland
Journal:  Genes Dev       Date:  2022-06-30       Impact factor: 12.890

2.  Polo-like kinase 4 is associated with advanced TNM stages and reduced survival and its inhibition improves chemosensitivity in colorectal cancer.

Authors:  Zhengang Duan; Lei Cai; Jin Cao; Wei Wu
Journal:  Oncol Lett       Date:  2022-06-20       Impact factor: 3.111

3.  lncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis.

Authors:  Yuan Yuan Ji; Man Meng; Ye Miao
Journal:  Cancer Manag Res       Date:  2020-11-09       Impact factor: 3.989

Review 4.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

5.  Circular RNA circ-ARFIP2 regulates proliferation, migration and invasion in human vascular smooth muscle cells via miR-338-3p-dependent modulation of KDR.

Authors:  Kun Qin; Ge Tian; Dong Zhou; Guangzhong Chen
Journal:  Metab Brain Dis       Date:  2021-04-10       Impact factor: 3.584

6.  CircKIF2A contributes to cell proliferation, migration, invasion and glycolysis in human neuroblastoma by regulating miR-129-5p/PLK4 axis.

Authors:  Yiheng Yang; Hongli Pan; Jie Chen; Zhonghua Zhang; Minna Liang; Xunqiang Feng
Journal:  Mol Cell Biochem       Date:  2021-02-25       Impact factor: 3.396

Review 7.  Molecular interactions of miR-338 during tumor progression and metastasis.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Biol Lett       Date:  2021-04-07       Impact factor: 5.787

8.  miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression.

Authors:  Wei Liu; Dunwei Wang; Lidi Liu; Lin Wang; Ming Yan
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-03       Impact factor: 8.886

Review 9.  An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma.

Authors:  Francesca Baldini; Matilde Calderoni; Laura Vergani; Paola Modesto; Tullio Florio; Aldo Pagano
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

10.  LINC00839 Regulates Proliferation, Migration, Invasion, Apoptosis and Glycolysis in Neuroblastoma Cells Through miR-338-3p/GLUT1 Axis.

Authors:  Lixia Yang; Liangyan Pei; Jilong Yi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.